Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of Shares sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.
Appears in 161 contracts
Samples: The Market Offering Agreement (Aprea Therapeutics, Inc.), Market Offering Agreement (Hoth Therapeutics, Inc.), The Market Offering Agreement (Vista Gold Corp)
Disclosure of Shares Sold. The Company will shall disclose in its Annual Reports quarterly reports on Form 10-Q and in its annual report on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of the Shares sold through the Manager Agent under this Agreement, the Net Proceeds net proceeds to the Company and the compensation paid by the Company with respect to sales of the Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.
Appears in 47 contracts
Samples: Equity Distribution Agreement (InspireMD, Inc.), Equity Distribution Agreement (Cellectar Biosciences, Inc.), Equity Distribution Agreement (Skye Bioscience, Inc.)
Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of Shares sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.
Appears in 21 contracts
Samples: Terms Agreement, Market Offering Agreement (Youngevity International, Inc.), Market Offering Agreement (India Globalization Capital, Inc.)
Disclosure of Shares Sold. The Company will shall disclose in its Annual Reports quarterly reports on Form 10-Q and in its annual report on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of the Shares sold through the Manager Agents under this Agreement, the Net Proceeds net proceeds to the Company and the compensation paid by the Company with respect to sales of the Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.
Appears in 9 contracts
Samples: Equity Distribution Agreement (Day One Biopharmaceuticals, Inc.), Equity Distribution Agreement (Prothena Corp Public LTD Co), Equity Distribution Agreement (Prothena Corp Public LTD Co)
Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 1020-K F and Quarterly Reports semi-annual or quarterly reports on Form 106-QK, as applicable, the number of Shares sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report report on Form 86-K or a further Prospectus Supplement.
Appears in 6 contracts
Samples: Market Offering Agreement (Genius Group LTD), Market Offering Agreement (Genius Group LTD), Market Offering Agreement (Guardforce AI Co., Ltd.)
Disclosure of Shares Sold. The Company will shall disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, Q and in its Annual Report on Form 10-K the number of the Shares sold through the Manager Agent under this Agreement, the Net Proceeds net proceeds to the Company and the compensation paid by the Company with respect to sales of the Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.
Appears in 5 contracts
Samples: Sales Agreement (Larimar Therapeutics, Inc.), Sales Agreement (Larimar Therapeutics, Inc.), Sales Agreement (Surrozen, Inc./De)
Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of Shares sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; , and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.
Appears in 5 contracts
Samples: Sales Agreement (NewAge, Inc.), Market Offering Agreement (Bridgeline Digital, Inc.), Market Offering Agreement (New Age Beverages Corp)
Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of Shares sold through the Manager Managers under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.
Appears in 4 contracts
Samples: Market Offering Agreement (India Globalization Capital, Inc.), At the Market Offering Agreement (India Globalization Capital, Inc.), The Market Offering Agreement (India Globalization Capital, Inc.)
Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of Shares sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.
Appears in 4 contracts
Samples: Market Offering Agreement (Cleanspark, Inc.), Market Offering Agreement (NextPlay Technologies Inc.), The Market Offering Agreement (Cleanspark, Inc.)
Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of Shares sold through the Manager Managers under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.
Appears in 4 contracts
Samples: Market Offering Agreement (Pear Therapeutics, Inc.), Market Offering Agreement (Uranium Energy Corp), Terms Agreement (Opgen Inc)
Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number amount of Placement Shares sold through the Manager under this AgreementAgents, the Net Proceeds to the Company and the compensation paid payable by the Company with respect to sales of the Agents respecting such Placement Shares pursuant to this Agreement during within the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplementperiod.
Appears in 4 contracts
Samples: Sales Agreement (ENDRA Life Sciences Inc.), ENDRA Life Sciences Inc., ENDRA Life Sciences Inc.
Disclosure of Shares Sold. The Company will shall disclose in its Annual Reports quarterly reports on Form 10-Q and in its annual report on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of the Shares sold through the Manager under this AgreementAgent hereunder, the Net Proceeds net proceeds to the Company and the compensation paid by the Company with respect to such sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.
Appears in 3 contracts
Samples: Equity Distribution Agreement (Aptevo Therapeutics Inc.), Equity Distribution Agreement (Aptevo Therapeutics Inc.), Equity Distribution Agreement (Aptevo Therapeutics Inc.)
Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of Shares sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company and the Trust with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.
Appears in 3 contracts
Samples: Market Offering Agreement (Air T Funding), Market Offering Agreement (Air T Funding), Air T Inc
Disclosure of Shares Sold. The Company will shall disclose in its Annual Reports quarterly reports on Form 10-Q and in its annual report on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of the Shares sold through the Manager Agent under this Agreement, the Net Proceeds to the Company Agreement and the compensation paid by net proceeds to the Company with respect to sales of the Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.
Appears in 2 contracts
Samples: Equity Distribution Agreement (Casa Systems Inc), Equity Distribution Agreement (Arvinas, Inc.)
Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 1020-F or on Form 6-K and Quarterly Reports on Form 10-Qwhen disclosing interim financial reports, as applicable, the number of Shares sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarterperiod; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 86-K or a further Prospectus Supplement.
Appears in 2 contracts
Samples: Market Offering Agreement (VivoPower International PLC), Market Offering Agreement (Aptorum Group LTD)
Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of Shares sold through or to the Manager Managers under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.
Appears in 2 contracts
Samples: Market Offering Agreement (Zedge, Inc.), Market Offering Agreement (Zedge, Inc.)
Disclosure of Shares Sold. The Company will shall disclose in its Annual Reports quarterly reports on Form 10-Q and in its annual report on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of the Shares sold through the Manager Agent under this Agreement, the Net Proceeds to the Company and the compensation paid by net proceeds to the Company with respect to sales of the Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.
Appears in 2 contracts
Samples: Equity Distribution Agreement (Fulcrum Therapeutics, Inc.), Equity Distribution Agreement (Fulcrum Therapeutics, Inc.)
Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of Shares sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplementsupplement to the Prospectus.
Appears in 2 contracts
Samples: The Market Offering Agreement (Windtree Therapeutics Inc /De/), Terms Agreement (Windtree Therapeutics Inc /De/)
Disclosure of Shares Sold. The Company will shall disclose in its Annual Reports quarterly reports on Form 10-Q and in its annual report on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of the Shares sold through the Manager Agents under this Agreement, the Net Proceeds to the Company Agreement and the compensation paid by net proceeds to the Company with respect to sales of the Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.
Appears in 2 contracts
Samples: Equity Distribution Agreement (Arvinas, Inc.), Equity Distribution Agreement (Arvinas, Inc.)
Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 1020-K and Quarterly Reports on Form 10-Q, as applicable, F the number of Shares sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarterperiod covered by the report; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report of Foreign Issuer on Form 86-K or a further Prospectus Supplement.
Appears in 2 contracts
Samples: Market Offering Agreement (Altamira Therapeutics Ltd.), Market Offering Agreement (Locafy LTD)
Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of Shares sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.. (q)
Appears in 1 contract
Samples: Market Offering Agreement (Caladrius Biosciences, Inc.)
Disclosure of Shares Sold. The Company will shall disclose in its Annual Reports quarterly reports on Form 10-Q and in its annual report on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of the Shares sold through the Manager Agents under this Agreement, the Net Proceeds net proceeds to the Company and the compensation paid by the Company with respect to sales of the Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement..
Appears in 1 contract
Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of Shares sold through the Manager Agents under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.
Appears in 1 contract
Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 1020-K F and Quarterly Reports semi-annual or quarterly reports on Form 106-QK, as applicable, the number of Shares sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 86-K or a further Prospectus Supplement.
Appears in 1 contract
Disclosure of Shares Sold. The Company will shall disclose in its Annual Reports quarterly reports on Form 10-Q and in its annual report on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of the Shares sold through the Manager under this AgreementAgent hereunder, the Net Proceeds net proceeds to the Company and the compensation paid by the Company with respect to sales of the Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.
Appears in 1 contract
Samples: Equity Distribution Agreement (Alpine Immune Sciences, Inc.)
Disclosure of Shares Sold. The Company will disclose in its Annual Reports Report on Form 1040-K F or 20-F and Quarterly Reports on Form 10-Q, as applicableits interim management’s discussion and analysis prepared and filed with the Commission, the number of Shares sold through the Manager Managers under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 86-K or a further Prospectus Supplement.
Appears in 1 contract
Samples: Terms Agreement (TRX GOLD Corp)
Disclosure of Shares Sold. The Company will shall disclose in its Annual Reports quarterly reports on Form 10-Q and in its annual report on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of the Shares sold through the Manager Agent under this Agreement, the Net Proceeds net proceeds to the Company and the compensation paid by the Company with respect to sales of the Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement..
Appears in 1 contract
Samples: Equity Distribution Agreement (Sigilon Therapeutics, Inc.)
Disclosure of Shares Sold. The Company will shall disclose in its Annual Reports quarterly reports on Form 10-Q and in its annual report on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of the Shares sold through the Manager Agent under this Agreement, the Net Proceeds net proceeds to the Company and the compensation paid by the Company with respect to sales of the Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.
Appears in 1 contract
Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of Shares sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 86-K or a further Prospectus Supplement.
Appears in 1 contract
Disclosure of Shares Sold. The To the extent required, the Company will disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of Shares sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.
Appears in 1 contract
Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 1020-K F and Quarterly Reports on Form 106-QK, as applicable, the number of Shares sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.
Appears in 1 contract
Disclosure of Shares Sold. The Company will shall disclose in its Annual Reports quarterly reports on Form 10-Q and in its annual report on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of Shares sold through the Manager Agent under this Agreement, the Net Proceeds net proceeds to the Company and the compensation paid by the Company with respect to sales of the Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.
Appears in 1 contract
Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 1020-K F or Form 40-F and Quarterly Reports semi-annual or quarterly reports on Form 106-QK, as applicable, the number of Shares sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 86-K or a further Prospectus Supplementother applicable form.
Appears in 1 contract
Samples: Market Offering Agreement (XORTX Therapeutics Inc.)
Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of Shares sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement..
Appears in 1 contract
Samples: Market Offering Agreement (ProMIS Neurosciences Inc.)
Disclosure of Shares Sold. The Company will shall disclose in its Annual Reports quarterly reports on Form 10-Q and in its annual report on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of the Shares sold through the Manager Agent under this Agreement, the Net Proceeds net proceeds to the Company and the compensation paid by the Company with respect to sales of the Shares pursuant to this Agreement during the relevant quarter; quarter and, if required by in the case of any subsequent change in Commission policy or request, more frequently by means of a Current Report annual report on Form 810-K or a further Prospectus SupplementK, during the fourth quarter of the applicable fiscal year.
Appears in 1 contract
Disclosure of Shares Sold. The Company will shall disclose in its Annual Reports quarterly reports on Form 10-Q and in its annual report on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of the Shares sold through the Manager Agents under this Agreement, the Net Proceeds net proceeds to the Company and the compensation paid by the Company with respect to sales of the Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement..
Appears in 1 contract
Samples: Independence Contract (Independence Contract Drilling, Inc.)
Disclosure of Shares Sold. The Company will disclose in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, the number of Shares sold through the Manager under this Agreement, Agreement and the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of Shares pursuant to this Agreement during the relevant quarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report on Form 8-K or a further Prospectus Supplement.
Appears in 1 contract
Samples: Market Offering Agreement (ENDRA Life Sciences Inc.)